116 related articles for article (PubMed ID: 38877445)
41. Outcomes following resection of intrahepatic cholangiocarcinoma.
Tabrizian P; Jibara G; Hechtman JF; Franssen B; Labow DM; Schwartz ME; Thung SN; Sarpel U
HPB (Oxford); 2015 Apr; 17(4):344-51. PubMed ID: 25395176
[TBL] [Abstract][Full Text] [Related]
42. Prognosis of Intrahepatic Cholangiocarcinomas with HBV Infection is Better than Those with Hepatolithiasis After R0 Liver Resection: A Propensity Score Matching Analysis.
Wang Q; Li J; Lei Z; Wu D; Si A; Wang K; Wang Y; Wan X; Lau WY; Shen F
Ann Surg Oncol; 2017 Jun; 24(6):1579-1587. PubMed ID: 28058554
[TBL] [Abstract][Full Text] [Related]
43. Defining Long-Term Survivors Following Resection of Intrahepatic Cholangiocarcinoma.
Bagante F; Spolverato G; Weiss M; Alexandrescu S; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Groot Koerkamp B; Guglielmi A; Itaru E; Pawlik TM
J Gastrointest Surg; 2017 Nov; 21(11):1888-1897. PubMed ID: 28840497
[TBL] [Abstract][Full Text] [Related]
44. Effectiveness of repeat hepatic resection for patients with recurrent intrahepatic cholangiocarcinoma: Factors associated with long-term outcomes.
Si A; Li J; Xing X; Lei Z; Xia Y; Yan Z; Wang K; Shi L; Shen F
Surgery; 2017 Apr; 161(4):897-908. PubMed ID: 27989605
[TBL] [Abstract][Full Text] [Related]
45. Intrahepatic cholangiocarcinoma prognostic determination using pre-operative serum C-reactive protein levels.
Lin ZY; Liang ZX; Zhuang PL; Chen JW; Cao Y; Yan LX; Yun JP; Xie D; Cai MY
BMC Cancer; 2016 Oct; 16(1):792. PubMed ID: 27733196
[TBL] [Abstract][Full Text] [Related]
46. Histologic factors affecting prognosis following hepatectomy for intrahepatic cholangiocarcinoma.
Uenishi T; Hirohashi K; Kubo S; Yamamoto T; Hamba H; Tanaka H; Kinoshita H
World J Surg; 2001 Jul; 25(7):865-9. PubMed ID: 11572025
[TBL] [Abstract][Full Text] [Related]
47. Development and Validation of a Laboratory Risk Score (LabScore) to Predict Outcomes after Resection for Intrahepatic Cholangiocarcinoma.
Tsilimigras DI; Mehta R; Aldrighetti L; Poultsides GA; Maithel SK; Martel G; Shen F; Koerkamp BG; Endo I; Pawlik TM;
J Am Coll Surg; 2020 Apr; 230(4):381-391.e2. PubMed ID: 32014569
[TBL] [Abstract][Full Text] [Related]
48. High Beclin-1 and ARID1A expression corelates with poor survival and high recurrence in intrahepatic cholangiocarcinoma: a histopathological retrospective study.
Bi C; Liu M; Rong W; Wu F; Zhang Y; Lin S; Liu Y; Wu J; Wang L
BMC Cancer; 2019 Mar; 19(1):213. PubMed ID: 30849962
[TBL] [Abstract][Full Text] [Related]
49. Fibrinogen/albumin ratio index is an independent predictor of recurrence-free survival in patients with intrahepatic cholangiocarcinoma following surgical resection.
Liu H; Qiu G; Hu F; Wu H
World J Surg Oncol; 2021 Jul; 19(1):218. PubMed ID: 34284775
[TBL] [Abstract][Full Text] [Related]
50. Impact of liver fibrosis score on prognosis after common therapies for intrahepatic cholangiocarcinoma: a propensity score matching analysis.
Zhang JX; Li P; Chen Z; Lin H; Cai Z; Liao W; Pan Z
BMC Cancer; 2020 Jun; 20(1):556. PubMed ID: 32539768
[TBL] [Abstract][Full Text] [Related]
51. Recurrence Patterns and Disease-Free Survival after Resection of Intrahepatic Cholangiocarcinoma: Preoperative and Postoperative Prognostic Models.
Doussot A; Gonen M; Wiggers JK; Groot-Koerkamp B; DeMatteo RP; Fuks D; Allen PJ; Farges O; Kingham TP; Regimbeau JM; D'Angelica MI; Azoulay D; Jarnagin WR
J Am Coll Surg; 2016 Sep; 223(3):493-505.e2. PubMed ID: 27296525
[TBL] [Abstract][Full Text] [Related]
52. Prognostic significance of neutrophil/prealbumin ratio for intrahepatic cholangiocarcinoma undergoing curative resection.
Huang XT; Huang CS; Li JH; Cai JP; Chen W; Yin XY
HPB (Oxford); 2018 Dec; 20(12):1215-1222. PubMed ID: 30078755
[TBL] [Abstract][Full Text] [Related]
53. Intrahepatic cholangiocarcinoma: analysis of 44 consecutive resected cases including 5 cases with repeat resections.
Saiura A; Yamamoto J; Kokudo N; Koga R; Seki M; Hiki N; Yamada K; Natori T; Yamaguchi T
Am J Surg; 2011 Feb; 201(2):203-8. PubMed ID: 19427630
[TBL] [Abstract][Full Text] [Related]
54. Negative impact of preoperative platelet-lymphocyte ratio on outcome after hepatic resection for intrahepatic cholangiocarcinoma.
Chen Q; Dai Z; Yin D; Yang LX; Wang Z; Xiao YS; Fan J; Zhou J
Medicine (Baltimore); 2015 Apr; 94(13):e574. PubMed ID: 25837750
[TBL] [Abstract][Full Text] [Related]
55. The impact of portal vein resection on outcomes for hilar cholangiocarcinoma: a multi-institutional analysis of 305 cases.
de Jong MC; Marques H; Clary BM; Bauer TW; Marsh JW; Ribero D; Majno P; Hatzaras I; Walters DM; Barbas AS; Mega R; Schulick RD; Choti MA; Geller DA; Barroso E; Mentha G; Capussotti L; Pawlik TM
Cancer; 2012 Oct; 118(19):4737-47. PubMed ID: 22415526
[TBL] [Abstract][Full Text] [Related]
56. Visceral infiltration of intrahepatic cholangiocarcinoma is most prognostic after curative resection - Retrospective cohort study of 102 consecutive liver resections from a single center.
Bartsch F; Baumgart J; Hoppe-Lotichius M; Schmidtmann I; Heinrich S; Lang H
Int J Surg; 2018 Jul; 55():193-200. PubMed ID: 29803768
[TBL] [Abstract][Full Text] [Related]
57. Higher content of microcystin-leucine-arginine promotes the survival of intrahepatic cholangiocarcinoma cells via regulating SET resulting in the poorer prognosis of patients.
Gu S; He W; Yan M; He J; Zhou Q; Yan X; Fu X; Chen J; Han X; Qiu Y
Cell Prolif; 2021 Feb; 54(2):e12961. PubMed ID: 33241617
[TBL] [Abstract][Full Text] [Related]
58. Long-term survival of patients with cholangiolocellular carcinoma after curative hepatectomy.
Ariizumi S; Kotera Y; Katagiri S; Nakano M; Nakanuma Y; Saito A; Yamamoto M
Ann Surg Oncol; 2014 Jun; 21 Suppl 3(Suppl 3):S451-8. PubMed ID: 24633664
[TBL] [Abstract][Full Text] [Related]
59. Outcome after liver resection for primary and recurrent intrahepatic cholangiocarcinoma.
Nickkholgh A; Ghamarnejad O; Khajeh E; Tinoush P; Bruckner T; Kulu Y; Mieth M; Goeppert B; Roessler S; Weiss KH; Hoffmann K; Büchler MW; Mehrabi A
BJS Open; 2019 Dec; 3(6):793-801. PubMed ID: 31832586
[TBL] [Abstract][Full Text] [Related]
60. Impact of stroma LOXL2 overexpression on the prognosis of intrahepatic cholangiocarcinoma.
Bergeat D; Fautrel A; Turlin B; Merdrignac A; Rayar M; Boudjema K; Coulouarn C; Sulpice L
J Surg Res; 2016 Jun; 203(2):441-50. PubMed ID: 27363654
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
